Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > First Trade A Takedown

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on May 20, 2022 11:47am

253 Views

Post# 34698478

RE:RE:First Trade A Takedown

Legit62 wrote: Pretty sad, but we will have to endure this nonsense till the fall, once we get more solid data and get closer to BTD and AA, no looking back, we wont be looking at 1,500 shares being traded, we will be in millions and institutional investors will drive this up.

We could have updates on the next financial at the end of the month.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China